Tremorine

Tremorine

Clinical data
ATC code	none
Identifiers
IUPAC name 1-(4-pyrrolidin-1-ylbut-2-ynyl)pyrrolidine
CAS Number	51-73-0
PubChem CID	5534
ChemSpider	5333
UNII	U817VZ1URQ
CompTox Dashboard (EPA)	DTXSID00199004
Chemical and physical data
Formula	C12H20N2
Molar mass	192.306 g·mol−1
3D model (JSmol)	Interactive image
SMILES C2CCCN2CC#CCN1CCCC1
InChI InChI=1S/C12H20N2/c1-2-8-13(7-1)11-5-6-12-14-9-3-4-10-14/h1-4,7-12H2 Key:JSUAJTLKVREZHV-UHFFFAOYSA-N

Tremorine is a drug which is used in scientific research to produce tremor in animals. This is used for the development of drugs for the treatment of Parkinson's disease, as tremor is a major symptom which is treated by anti-Parkinson's drugs. ^{[1] [2] [3] [4] [5]} Beta blockers are also effective in counteracting the effects of tremorine. ^[6]

History

Tremorine was first reported by Everett et al. in 1956-57. ^{[7] [8] [9] [10]}

References

1. Trautner EM, Gershon S (May 1959). "Use of tremorine for screening anti-parkinsonian drugs". Nature. 183 (4673): 1462–3. Bibcode:1959Natur.183.1462T. doi:10.1038/1831462a0. PMID   13657170. S2CID   4173699.
2. Friedman AH, Aylesworth RJ, Friedman G (September 1963). "Tremorine: Its Effect on Amines of the Central Nervous System". Science. 141 (3586): 1188–90. Bibcode:1963Sci...141.1188F. doi:10.1126/science.141.3586.1188. PMID   14043364. S2CID   37472968.
3. Menon M, Clark WG, Aures D (1971). "Effect of tremorine, oxotremorine and decaborane on brain histamine levels in rats". Pharmacological Research Communications. 3 (4): 345–350. doi:10.1016/0031-6989(71)90005-1.
4. Shinozaki H, Hirate K, Ishida M (May 1985). "Further studies on quantification of drug-induced tremor in mice: effects of antitremorgenic agents on tremor frequency". Experimental Neurology. 88 (2): 303–15. doi:10.1016/0014-4886(85)90193-1. PMID   3987859. S2CID   7607662.
5. Morais LC, Quintans-Júnior LJ, Franco CI, Almeida JR, Almeida RN (December 2004). "Antiparkinsonian-like effects of Plumbago scandens on tremorine-induced tremors methodology". Pharmacology, Biochemistry, and Behavior. 79 (4): 745–9. doi:10.1016/j.pbb.2004.10.004. PMID   15582683. S2CID   28371865.
6. Paul V (1986). "The role of adrenergic mechanism in tremorine-induced tremors in rats: antitremor effect of beta-adrenoceptor antagonists". Indian Journal of Physiology and Pharmacology. 30 (4): 307–12. PMID   2883120.
7. Everett, Guy M. (1956). "Tremor produced by drugs". Nature v. 177(4522), p. 1238. ("In the routine screening of drugs in mice, we have found only ten out of ten thousand compounds which produce sustained tremor. One of these, 1-4 dipyrrolidino-2-butyne, 'Tremorine', in doses of 5–20 mgm./kgm. produces tremor, salivation, meiosis, etc."
8. Everett G.M., Blockus L.E. and Sheppard I.M. (1956). "Tremor induced by tremorine and its antagonism by anti-Parkinson drugs." Science v. 124, p.79.
9. Everett G.M., Blockus L.E., Sheppard I.M. and Toman J.E.P. (1956), Federation Proceedings v. 15, p. 420.
10. Blockus, L. E. and Everett, G. M. (January 1957). "Tremor producing drug 1,4 di-pyrrolidino-2-butyne (Tremorine)", Federation Proceedings v. 16(1), p. 283.

See also

• Oxotremorine